
Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript
Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2025 Earnings Call Transcript May 15, 2025 Gossamer Bio, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.18. Bryan Giraudo – COO & CFO: Faheem Hasnain – Co-Founder, CEO, President …